/ Pharmaceutical chemistry Content for �������ϲ����Ͽ� Davis en /health/news/researchers-step-closer-mimicking-natures-mastery-chemistry <p class="paragraph"><span><span><span>I<span>n nature, organic molecules are either left- or right-handed, but synthesizing molecules with a specific “handedness” in a lab is hard to do.</span> Make a drug or enzyme with the wrong “handedness,” and it just won’t work. Now chemists at the University of California, Davis, are getting closer to mimicking nature’s chemical efficiency through computational modeling and physical experimentation. &nbsp;</span></span></span></p> January 10, 2024 - 8:45am Andy Fell /health/news/researchers-step-closer-mimicking-natures-mastery-chemistry /health/news/uc-davis-establishes-institute-psychedelics-and-neurotherapeutics <p><span><span><span><span><span><span><span><span>The University of California, Davis, has launched the <a href="https://neurotherapeutics.ucdavis.edu/"><strong>Institute for Psychedelics and Neurotherapeutics</strong></a> to advance basic knowledge about the mechanisms of psychedelics and translate it into safe and effective treatments for diseases such as depression, post-traumatic stress disorder, addiction, Alzheimer’s disease and Parkinson’s disease, among others.</span></span></span></span></span></span></span></span></p> February 02, 2023 - 5:00am Andy Fell /health/news/uc-davis-establishes-institute-psychedelics-and-neurotherapeutics /news/psychlight-sensor-enable-discovery-new-psychiatric-drugs Introducing psychLight: a sensor for mental illness treatment and drug abuse detection. Learn how �������ϲ����Ͽ� Davis researchers are advancing mental health technology. April 28, 2021 - 8:30am Andy Fell /news/psychlight-sensor-enable-discovery-new-psychiatric-drugs /news/new-compound-related-psychedelic-ibogaine-could-treat-addiction-depression <p>A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers at the University of California, Davis. A paper describing the work is published Dec. 9 in Nature.</p> <p>“Psychedelics are some of the most powerful drugs we know of that affect the brain,” said David Olson, assistant professor of chemistry at �������ϲ����Ͽ� Davis and senior author on the paper. “It’s unbelievable how little we know about them.”</p> December 09, 2020 - 8:08am Andy Fell /news/new-compound-related-psychedelic-ibogaine-could-treat-addiction-depression